
Synthetic thymosin β4 fragment for in-vitro laboratory characterisation.
TB-500 is a synthetic research peptide corresponding to a defined region of the naturally occurring protein thymosin β4. It is referenced in in-vitro laboratory literature primarily in the context of peptide characterisation and cellular actin-binding studies.
Our TB-500 is manufactured to strict laboratory standards and independently third-party tested for identity and purity, providing well-documented material for laboratory workflows.
TB-500 is referenced in laboratory literature in fields including:
All work described in the scientific literature is conducted in controlled in-vitro laboratory environments.
Every batch of TB-500 supplied by NXT GEN PEPTIDES is independently third-party tested for identity and purity, giving researchers consistent, well-documented material for their laboratory workflow.
Store lyophilised at -20 °C. After reconstitution, store at 2–8 °C and use within 28 days.
This product is supplied exclusively for scientific and laboratory research. It is not intended for human or veterinary consumption, administration, diagnosis, treatment or therapeutic use.

Triple agonist research peptide (GLP-1/GIP/glucagon).

Synthetic pentadecapeptide fragment for in-vitro laboratory characterisation.

Copper tripeptide-1 for in-vitro biochemical characterisation.

Bundle: BPC-157 10 mg and TB-500 10 mg supplied together at a research-lab discount.